Company news

Sartorius Stedim Biotech Sa (EURONEXT:DIM) news

Sartorius Stedim Biotech Sa news releases on 6ix. Latest, Oct 1, 2026: Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING…

View Sartorius Stedim Biotech Sa →

Press releases & updates

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

September 30, 2026

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

September 30, 2026

Sartorius Stedim Biotech continues positive development and expands profitable growth

July 23, 2026

Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026

April 23, 2026

Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.

March 24, 2026

Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets

March 17, 2026

Sartorius Stedim Biotech releases Universal Registration Document 2025

February 16, 2026

Sartorius Stedim Biotech SA: Information on Document Availability

February 16, 2026

Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros

February 6, 2026

Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook

February 3, 2026

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

January 6, 2026

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

November 3, 2025

Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025

October 16, 2025

Sartorius Stedim Biotech and Nanotein Technologies Partner to Advance Cell Therapy Manufacturing

August 11, 2025

Bio Usawa Biotechnology and Sartorius Stedim Biotech Forge Partnership to Pioneer Biopharmaceutical Manufacturing in Africa

July 29, 2025

Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up Sensible’s Unique Cell-Based mRNA Design and Manufacturing Platform

July 9, 2025